首页> 外文会议>2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING >Comparative Evaluation of Paraoxonase and SGOT in Female Cardiac Patient with Normal Subjects
【24h】

Comparative Evaluation of Paraoxonase and SGOT in Female Cardiac Patient with Normal Subjects

机译:女性心脏正常患者心脏中对氧磷酶和SGOT的比较评价

获取原文

摘要

Cardiac disease is associated with significantly decrease activity of paraoxonase (PON) as compared to the controls. The present project was design for the comparative evaluation of PON and SGOT in female cardiac patents and normal subjects. Other biochemical test low HDL cholesterol HDL-C is an established indicator for coronary heart disease. Also clear cause and effective relationship between LDL oxidation and atherosclerosis was seen. According to the global risk assessment score for cardiovascular risk production age, gender, total and HDL cholesterol, oxidized HDL, diabetes, hypertension and smoking are predictive values for coronary artery disease. So based on such facts the present work was to determine the PON activity in cardiac disease and normal female subjects at the same time it was compared with other biochemical tests. The blood of female cardiac patients as well as control subjects was collected and serum was separated. The serum was used for assaying of enzymes PON and SGOT. Because PON is located on HDL and prevents the oxidation of LDL. So these two parameters were also determined. The female cardiac patients had low activity of PON and HDL as compared to normal subjects. On the other hand the activity of SGOT and LDL was greater in cardiac patients as compared to normal subjects. the activity of PON (55.38±3.07 U mL-1) and HDL (29.70±2.00 mg dL- 1) was lower and activity of SGOT (219.0±1.57 U mL-1) and LDL (164.7±0.88 mg dL-1) was greater in cardiac female patients as compared to normal female subject (223.6±3.02 U mL-1), (49.04 mg dL-1), (19.86 U mL-1) and (122.5±2.17 mg dL-1) respectively in above mentioned biochemical tests. It was concluded from this work that PON and SGOT were inversely correlated and HDL and PON are related to each other. The value of LDL increase as PON activity decrease. Breakthrough work to be presented: PON has recently attracted attention as a protective factor against oxidative modification of LDL and may therefore play role in atherosclerosis. The unearthing of paraoxonase enzyme activity open a probable innovative route in anticipation of heart disease.
机译:与对照组相比,心脏疾病与对氧磷酶(PON)的活性显着降低有关。本项目旨在对女性心脏专利和正常受试者的PON和SGOT进行比较评估。其他生化测试低HDL胆固醇HDL-C是冠心病的既定指标。还发现了低密度脂蛋白氧化与动脉粥样硬化之间的明确原因和有效关系。根据心血管疾病风险产生年龄,性别,总胆固醇和高密度脂蛋白胆固醇,氧化高密度脂蛋白,糖尿病,高血压和吸烟的全球风险评估得分,可预测冠状动脉疾病的价值。因此,基于这些事实,目前的工作是在与其他生化测试进行比较的同时,确定心脏病和正常女性受试者中的PON活性。采集女性心脏患者以及对照组的血液,并分离血清。血清用于测定酶PON和SGOT。因为PON位于HDL上,可防止LDL氧化。因此,这两个参数也已确定。与正常受试者相比,女性心脏病患者的PON和HDL活性较低。另一方面,与正常人相比,心脏病患者的SGOT和LDL活性更高。 PON(55.38±3.07 U mL-1)和HDL(29.70±2.00 mg dL-1)的活性较低,SGOT(219.0±1.57 U mL-1)和LDL(164.7±0.88 mg dL-1)的活性较低与上述正常女性受试者相比,心脏病女性患者的受试者分别更高(223.6±3.02 U mL-1),(49.04 mg dL-1),(19.86 U mL-1)和(122.5±2.17 mg dL-1)。提到生化测试。从这项工作可以得出结论,PON和SGOT是负相关的,而HDL和PON是相互相关的。 LDL的值随PON活性的降低而增加。即将提出的突破性工作:PON最近作为LDL氧化修饰的保护因子而受到关注,因此可能在动脉粥样硬化中发挥作用。对氧磷酶活性的发掘为预期心脏病开辟了一条可能的创新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号